Laurion Capital Management’s Immunic IMUX Stock Holding History

Laurion Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.68M	Hold	610,326	–	–	0.09%	210
2026 Q2	$9.38M	Buy	610,326 +222,110	+57%	+$2.74M	0.24%	96
2026 Q1	$4.31M	Hold	388,216	–	–	0.19%	145
2025 Q4	$2.07M	Buy	388,216 +200,000	+106%	+$1.47M	0.08%	105
2025 Q3	$1.66M	Sell	188,216 -2,290	-1%	-$20.2K	0.03%	169
2025 Q2	$1.33M	Buy	190,506 +167,663	+734%	+$1.54M	0.02%	189
2025 Q1	$249K	Buy	+22,843	New	+$247K	0.01%	223
2014 Q4	–	Sell	-29	Closed	-$241K	–	377
2014 Q3	$241K	Sell	29 -8	-22%	-$75.5K	0.01%	248
2014 Q2	$406K	Buy	+37	New	+$260K	0.01%	240

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Laurion Capital Management's IMUX Position: Q3 2026 in Review

Laurion Capital Management held its Immunic (IMUX) position steady in Q3 2026 at 610,326 shares worth $5.68M. The position accounts for 0.09% of the portfolio, ranked #210.

Laurion Capital Management first reported a position in IMUX in Q2 2014 and has held it in 9 quarters since. The position peaked at $9.38M in Q2 2026. 49 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

Laurion Capital Management held 610,326 shares of Immunic worth $5.68M as of Q3 2026.
Laurion Capital Management left its Immunic share count unchanged in Q3 2026.
Immunic made up 0.09% of Laurion Capital Management's portfolio in Q3 2026, its #210 holding.
Laurion Capital Management first reported a position in Immunic in Q2 2014 and has held it in 9 quarters since.
Laurion Capital Management's Immunic position peaked at $9.38M in Q2 2026.
49 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Laurion Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.